Amide Technologies

Exciting News from Amide Technologies! As we gear up for a dynamic week with two major conferences (#PEGS and #TIDES) right here in Boston, we're thrilled to showcase our cutting-edge capabilities in peptide synthesis, pioneered at MIT and refined in the heart of Kendall Square. ? ?What We Offer: ·??????Rapid, High-Fidelity Flow-Based Synthesis: From milligrams to grams, expect expedited delivery within just 4 weeks. ·??????Long Peptides: Specializing in peptides up to 120 amino acids, including complex ubiquitin variants. ·??????Advanced Modifications: Our expertise extends to branched peptides, complex structures, and post-translational modifications—think dyes, biotins, pegs, and acetyl groups. ·??????Hydrophobic Long Peptides: Tailored for specialized research needs, innovating in life sciences. ·??????GPCR Multi-Agonists: Expertly designed to target GPCR pathways with multimeric flow synthesis, enhancing receptor activation for groundbreaking research. ? Special Highlights: Kyuto Tashiro, Researcher at Amide Technologies, will be presenting a poster at #PEGS. Don't miss this opportunity to dive deep into our latest research! Mark Simon ([email protected]), CEO of Amide Technologies, will be attending both #PEGS and #TIDES, eager to connect with fellow innovators and discuss future collaborations. Located conveniently near the conference venues in vibrant Kendall Square, we invite attendees to learn more about how Amide Technologies can support your research and development projects with unparalleled precision and speed. ? ?Visit us at www.AmideTech.com ? Let's innovate together—transforming challenges into opportunities with advanced peptide synthesis! ? #PeptideSynthesis #FlowChemistry #PeptideTherapeutics?#Biotechnology #Innovations #BostonConferences #PEGS #TIDES #AmideTechnologies

Today we officially announced the commercialization of Amide’s peptide manufacturing platform and the recent closing of our Series A Extension, led by?Engine Ventures. Mark Simon?and?Philip Dixon?spoke to?Anna Brown of?Endpoints News?to discuss their vision for the future and detail how their platform is accelerating peptide drug discovery. Thank you Brad L. Pentelute, Biological Engineering Ventures, Engine Ventures, and Forcefield Venture for supporting Amide in developing this platform. To learn more about Amide Technologies, visit our newly redesigned website at?amidetech.com. https://lnkd.in/eFzhAD8d